Evaluation of effect of Asanadi Gana Kwatha Ghana Wati on Cholesterol

A Randomized controlled clinical trial to evaluate the efficacy of Asanadi Gana Kwatha Ghana Vati in the management of dyslipidemia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/031355

Enrollment

142

Registered

2021-02-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I52- Other heart disorders in diseasesclassified elsewhere

Interventions

Intervention1: Asanadi Gana Kwath Ghana Wati: Asanadi Gana Kwath Ghana Wati 1 gm BD for 3 months Control Intervention1: Asanadi Gana Kwath Ghana Wati: Asanadi Gana Kwath Ghana Wati 1000mg BD for 3 mon

Eligibility

Inclusion criteria

Inclusion criteria: Subjects having Dyslipidemia, willing to participate in trial

Exclusion criteria

Exclusion criteria: Subjects not willing for trial, diabetic patients, uncontrolled hypo/hyper thyroidism, chronic hepatic & renal failure, ECG demonstrating arrhythmia, Pregnant & Lactating women

Design outcomes

Primary

Measure	Time frame
Patients of Dyslipidemia would be treated with classical Ayurvedic formulation Asanadi Gana Kwath Ghana Wati and analysis of result would be done. Assessment of Values of Lipids will be done.Timepoint: at baseline 0 day, 30 day,60day,90day	—

Secondary

Measure	Time frame
this trial will make us know demographic details regarding- Age, Sex and evidence of dyslipidemiaTimepoint: 12 weeks	—

Countries

India

Contacts

Public ContactSomadatta Bhaskarrao Kulkarni

CSMSS Ayurved Mahavidyalaya, Kanchanwadi, Aurngabad

dr.shrikantgdeshmukh@gmail.com9921553999

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026